{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20210528",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1/4",
          "submission_class_code_description": "Type 1 - New Molecular Entity and Type 4 - New Combination",
          "application_docs": [
            {
              "id": "67637",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/213378Orig1s000, Orig2s000ltr.pdf",
              "date": "20210601",
              "type": "Letter"
            },
            {
              "id": "67640",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213378s000lbl.pdf",
              "date": "20210601",
              "type": "Label"
            },
            {
              "id": "67903",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/213378Orig1Orig2s000TOC.html",
              "date": "20210625",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "8",
          "submission_status": "AP",
          "submission_status_date": "20250228",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "81402",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/213378s008lbl.pdf",
              "date": "20250303",
              "type": "Label"
            },
            {
              "id": "81403",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/213378s008lbl.pdf#page=41",
              "date": "20250303",
              "type": "Medication Guide"
            },
            {
              "id": "81424",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/213378Orig1s008ltr.pdf",
              "date": "20250304",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "11",
          "submission_status": "AP",
          "submission_status_date": "20260130",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "84896",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/213378Orig1s011ltr.pdf",
              "date": "20260203",
              "type": "Letter"
            },
            {
              "id": "84947",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/213378s011lbl.pdf",
              "date": "20260205",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20210528",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1/4",
          "submission_class_code_description": "Type 1 - New Molecular Entity and Type 4 - New Combination",
          "application_docs": [
            {
              "id": "67638",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/213378Orig1s000, Orig2s000ltr.pdf",
              "date": "20210601",
              "type": "Letter"
            },
            {
              "id": "67639",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213378s000lbl.pdf",
              "date": "20210601",
              "type": "Label"
            },
            {
              "id": "67904",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/213378Orig1Orig2s000TOC.html",
              "date": "20210625",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "9",
          "submission_status": "AP",
          "submission_status_date": "20250122",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "81027",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/213378s009lbl.pdf",
              "date": "20250205",
              "type": "Label"
            },
            {
              "id": "81162",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/213378Orig1s009ltr.pdf",
              "date": "20250207",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "7",
          "submission_status": "AP",
          "submission_status_date": "20240130",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "77360",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/213378Orig1s007ltr.pdf",
              "date": "20240131",
              "type": "Letter"
            },
            {
              "id": "77362",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/213378s007lbl.pdf",
              "date": "20240131",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20230925",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "75565",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213378Orig1s005lbl.pdf",
              "date": "20230926",
              "type": "Label"
            },
            {
              "id": "75566",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/213378Orig1s005ltr.pdf",
              "date": "20230926",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "NDA213378",
      "sponsor_name": "ALKERMES INC",
      "openfda": {
        "application_number": [
          "NDA213378"
        ],
        "brand_name": [
          "LYBALVI"
        ],
        "generic_name": [
          "OLANZAPINE AND SAMIDORPHAN L-MALATE"
        ],
        "manufacturer_name": [
          "Alkermes, Inc."
        ],
        "product_ndc": [
          "65757-651",
          "65757-652",
          "65757-653",
          "65757-654"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "OLANZAPINE",
          "SAMIDORPHAN L-MALATE"
        ],
        "rxcui": [
          "2570392",
          "2570398",
          "2570399",
          "2570401",
          "2570402",
          "2570404",
          "2570405",
          "2570407"
        ],
        "spl_id": [
          "44ae69cc-b9a6-4658-90fa-1dbef1e97eb4"
        ],
        "spl_set_id": [
          "32ffddd1-4e2b-45d9-9b36-bb730167ec80"
        ],
        "package_ndc": [
          "65757-651-40",
          "65757-651-41",
          "65757-651-42",
          "65757-651-44",
          "65757-652-40",
          "65757-652-41",
          "65757-652-42",
          "65757-652-44",
          "65757-653-40",
          "65757-653-41",
          "65757-653-42",
          "65757-653-44",
          "65757-654-40",
          "65757-654-41",
          "65757-654-42",
          "65757-654-44"
        ],
        "nui": [
          "N0000175430"
        ],
        "pharm_class_epc": [
          "Atypical Antipsychotic [EPC]"
        ],
        "unii": [
          "0AJQ5N56E0",
          "N7U69T4SZR"
        ]
      },
      "products": [
        {
          "product_number": "003",
          "reference_drug": "Yes",
          "brand_name": "LYBALVI",
          "active_ingredients": [
            {
              "name": "OLANZAPINE",
              "strength": "15MG"
            },
            {
              "name": "SAMIDORPHAN L-MALATE",
              "strength": "EQ 10MG BASE"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "LYBALVI",
          "active_ingredients": [
            {
              "name": "OLANZAPINE",
              "strength": "5MG"
            },
            {
              "name": "SAMIDORPHAN L-MALATE",
              "strength": "EQ 10MG BASE"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "004",
          "reference_drug": "Yes",
          "brand_name": "LYBALVI",
          "active_ingredients": [
            {
              "name": "OLANZAPINE",
              "strength": "20MG"
            },
            {
              "name": "SAMIDORPHAN L-MALATE",
              "strength": "EQ 10MG BASE"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "002",
          "reference_drug": "Yes",
          "brand_name": "LYBALVI",
          "active_ingredients": [
            {
              "name": "OLANZAPINE",
              "strength": "10MG"
            },
            {
              "name": "SAMIDORPHAN L-MALATE",
              "strength": "EQ 10MG BASE"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}